Compatibility and stability of fentanyl admixtures in polypropylene syringes

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 1, 1998, Pages 67-72

  Peterson, G M ^a   Miller, K A ^a   Galloway, J G ^b   Dunne, P F ^c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

^c Repatriation General Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; METOCLOPRAMIDE; MIDAZOLAM; SCOPOLAMINE BUTYL BROMIDE;

ARTICLE; DARKNESS; DRUG DETERMINATION; DRUG MIXTURE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; STORAGE;

ADJUVANTS, ANESTHESIA; ANESTHETICS, INTRAVENOUS; ANTIEMETICS; DRUG COMBINATIONS; DRUG STABILITY; DRUG STORAGE; FENTANYL; HUMANS; METOCLOPRAMIDE; MIDAZOLAM; PALLIATIVE CARE; POLYPROPYLENES; SCOPOLAMINE; SYRINGES; TEMPERATURE;

EID: 0031824851     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00141.x     Document Type: Article

References (23)

1. Reid DB. (1989) The syringe driver in hospice care. A useful tool. Current Therapeutics, 30, 15-19.
2. Drummond SH, Peterson GM, Galloway JG, Keefe PA. (1996) National survey of drug use in palliative care. Palliative Medicine, 10, 119-124.
3. Storey P, Hill HH Jr, St Louis RH, Tarver EE. (1990) Subcutaneous infusions for control of cancer symptoms. Journal of Pain and Symptom Management, 5, 33-41.
4. Maddocks I. (1992) Subcutaneous administration of fluid and drugs in palliative care. Australian Journal of Hospital Pharmacy, 22, 181-184.
5. O'Neill WM. (1994) Subcutaneous infusions - a medical last rite. Palliative Medicine, 8, 91-93.
6. Bottomley DM, Hanks GW. (1990) Subcutaneous midazolam infusion in palliative care. Journal of Cain and Symptom Management, 5, 259-261.
7. Amesbury BDW, Dunphy KP. (1989) The use of subcutaneous midazolam in the home care setting. Palliative Medicine, 3, 299-301.
8. Ahmedzai S. (1997) New approaches to pain control in patients with cancer. European Journal of Cancer, 33 (Suppl. 6), S8-14.
9. Mercadente S. (1995) Tolerability of continuous subcutaneous octreotide used in combination with other drugs. Journal of Palliative Care, 11, 14-16.
10. Currow DC, Coughlan M, Fardell B, Cooney NJ. (1997) Use of ondansetron in palliative medicine. Journal of Pain and Symptom Management, 13, 302-307.
11. Agency for Health Care Policy and Research. (1994) Management of cancer pain: adults. American Journal of Hospital Pharmacy, 51, 1643-1656.
12. Miller RS, Peterson GM, Abbott F, Maddocks I, Parker D. (1995) Plasma levels of fentanyl with subcutaneous infusion in palliative care patients. British Journal of Clinical Pharmacology, 40, 553-556.
13. Paix A, Coleman A, Lees J, et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain, 63, 263-269.
14. Ohlsson LJ, Rydberg TS, Eden T, Glimhall BAK, Thulin LA. (1995) Microbiologic and economic evaluation of multiday infusion pumps for control of cancer pain. Annals of Phamacotherapy, 29, 972-976.
15. Duafala ME, Kleinberg ML, Nacov C, et al. (1990) Stability of morphine sulfate in infusion devices and containers for intravenous administration. American Journal of Hospital Pharmacy, 47, 143-146.
16. Yeo W, Lam KK, Chan AT, Leung TW, Nip SY, Johnson PJ. (1997) Transdermal fentanyl for severe cancer-related pain. Palliative Mediane, 11, 233-239.
17. Peterson GM, Khoo BHC, Galloway JG, Paterson JA. (1991) Preliminary study of the stability of midazolam in polypropylene syringes. Australian Journal of Hospital Pharmacy, 21, 115-118.
18. Stiles ML, Tu YH, Allen LV Jr. (1989) Stability of morphine sulfate in portable pump reservoirs during storage and simulated administration. American Journal of Hospital Pharmacy, 46, 1404-1407.
19. Gove LF, Gordon NH, Miller J, Scott W. (1985) Prefilled syringes for self-administration of epidural opiates. Pharmaceutical Journal, 234, 378-379.
20. Targett PL, Keefe PA, Merridew CG. (1997) Compatibility and stability of drug adjuvants and morphine tartrate in 10 mL polypropylene syringes. Australian Journal of Hospital Pharmacy, 27, 207-212.
21. Pramar YV, Loucas VA, El-Rachidi A. (1997) Stability of midazolam hydrochloride in syringes and i.v. fluids. American Journal of Health-System Pharmacy, 54, 913-915.
22. Grassby PF, Hutchings L. (1997) Drug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidol. Palliative Medicine, 11, 217-224.
23. Mitrano FP, Baptista RJ, Newton DW, Augustine SC. (1986) Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump. American Journal of Hospital Pharmacy, 43, 78-80.